Similar articles

• A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.

  Singh H, Usher S, Johnson D, Poulos A. Singh H, et al. J Lipid Res. 1990 Feb;31(2):217-25. J Lipid Res. 1990. PMID: 1691260
• Peroxisomal disorders.

  Moser HW, Bergin A, Cornblath D. Moser HW, et al. Biochem Cell Biol. 1991 Jul;69(7):463-74. doi: 10.1139/o91-070. Biochem Cell Biol. 1991. PMID: 1724376 Review.
• Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.

  Slawecki ML, Dodt G, Steinberg S, Moser AB, Moser HW, Gould SJ. Slawecki ML, et al. J Cell Sci. 1995 May;108 ( Pt 5):1817-29. doi: 10.1242/jcs.108.5.1817. J Cell Sci. 1995. PMID: 7544797
• Formation of a novel arachidonic acid metabolite in peroxisomes.

  Gordon JA, Heller SK, Rhead WJ, Watkins PA, Spector AA. Gordon JA, et al. Prostaglandins Leukot Essent Fatty Acids. 1995 Feb-Mar;52(2-3):77-81. doi: 10.1016/0952-3278(95)90001-2. Prostaglandins Leukot Essent Fatty Acids. 1995. PMID: 7540307
• Peroxisomal disorders. Neurodevelopmental and biochemical aspects.

  Brown FR 3rd, Voigt R, Singh AK, Singh I. Brown FR 3rd, et al. Am J Dis Child. 1993 Jun;147(6):617-26. doi: 10.1001/archpedi.1993.02160300023015. Am J Dis Child. 1993. PMID: 7685145 Review.